Study to Evaluate the Effectiveness of StaphVAX in Adults on Hemodialysis
NCT00071214 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 3600
Last updated 2006-07-11
Summary
Two part study testing the effectiveness and safety of StaphVAX vaccine in chronic hemodialysis patients against infection by Staphylococcus aureus.
Conditions
- Staphylococcal Infections
- Kidney Failure, Chronic
Interventions
- BIOLOGICAL
-
S. aureus Type 5 and 8 Capsular Polysaccharide Conjugate Vaccine
Sponsors & Collaborators
-
Nabi Biopharmaceuticals
lead INDUSTRY
Principal Investigators
-
Matt Hohenboken, MD, PhD · Nabi Biopharmaceuticals
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-09-30
- Completion
- 2005-09-30
More Related Trials
-
StaphVAX Immunogenicity and Safety in Orthopaedic Joint Surgery
NCT00211965 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Staphylococcal Investigational Vaccine in Healthy Adults
NCT01160172 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial to Evaluate a Recombinant Staphylococcus Aureus Vaccine (Escherichia Coli) in Healthy Adults
NCT02804711 ·Status: COMPLETED ·Phase: PHASE1
-
A Comparability Study of the Phase 3 Lot and a Single Commercial Lot of NicVAX in Healthy Adult Smokers
NCT01375933 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Immunogenicity and Efficacy of GSK S. Aureus Candidate Vaccine (GSK3878858A) When Administered to Healthy Adults (Dose-escalation) and to Adults 18 to 64 Years of Age With a Recent S. Aureus Skin and Soft Tissue Infection (SSTI)
NCT04420221 ·Status: COMPLETED ·Phase: PHASE2
-
A Human Monoclonal Antibody Against Staphylococcus Aureus Alpha Toxin in Mechanically Ventilated Adult Subjects - 2
NCT05331885 ·Status: TERMINATED ·Phase: PHASE3
-
Study to Evaluate the Safety and Effectiveness of Zostavax™ in Subjects 50 - 59 Years of Age (V211-022)
NCT00534248 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of a Single Vaccination of One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) and a Single Dose Level of a 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) in Healthy Adults Aged 65 to <86 Years
NCT01643941 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity of a Klebsiella Pneumoniae Tetravalent Bioconjugate Vaccine (Kleb4V)
NCT04959344 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Antibody and Safety Study of 6 Doses of NicVAX in Smokers
NCT00598325 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Immune Response in Dialysis Patients Vaccinated Against COVID-19
NCT04805632 ·Status: COMPLETED
-
A Clinical Trial to Evaluate a Recombinant Staphylococcus Aureus Vaccine (Escherichia Coli) in Healthy Adults
NCT03966040 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 2b, Randomized, Double-blind, Active-controlled Study of Single Dose CVXGA Intranasal COVID-19 Vaccine in Adults
NCT06742281 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years
NCT01364571 ·Status: COMPLETED ·Phase: PHASE1
-
ZOSTAVAX™ Safety Study in Subjects ≥ 60 Years of Age (V211-020)
NCT00550745 ·Status: COMPLETED ·Phase: PHASE4
-
ZOSTAVAX™ (Zoster Vaccine Live) Long-term Effectiveness Study (V211-024)
NCT01600079 ·Status: COMPLETED
-
A Study of Anthrax Vaccines Px563L and RPA563 in Healthy Adult Subjects
NCT02655549 ·Status: COMPLETED ·Phase: PHASE1
-
ZOSTAVAX® in Renal Transplant Patients
NCT01137669 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I/II, Dose-finding Study to Assess the Safety, Reactogenicity, and Immunogenicity of a Broadly Protective Sarbecovirus Vaccine (GBP511) in Healthy Adults.
NCT07280858 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
ZOSTAVAX™ Administered Concomitantly With PNEUMOVAX™ 23 (V211-012)(COMPLETED)
NCT00535730 ·Status: COMPLETED ·Phase: PHASE3
-
Trial to Evaluate the Safety, Tolerability, and Immunogenicity of A Multivalent Group B Streptococcus Vaccine When Administered Concomitantly With Tdap in Healthy Nonpregnant Women
NCT04766086 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Adult (18-40 Years Old)
NCT01123941 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of a Single Vaccination With a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years
NCT02364596 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I STEBVax in Healthy Adults
NCT00974935 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Feasibility of TA-CIN Vaccine in HPV16 Associated Cervical Cancer
NCT02405221 ·Status: COMPLETED ·Phase: PHASE1